Limitations of PIV Biomarker Analysis Related to Chemoradiotherapy and Unadjusted Confounders.
Hongbo Gao, Wencai Weng
原始摘要（英文原文）· Original abstract
The pan-immune-inflammation value (PIV) derived from four blood cell counts warrants cautious interpretation in rectal-cancer immunotherapy, as CRT cannot be disentangled from anti-PD-1 effects within the small n = 16 subgroup.